HeartMate 3 LVAD Patient Education
Patients with advanced heart failure may not fully grasp that heart failure is a serious, progressive disease. They may not realize how sick they truly are until it’s too late.
You can help your patients understand if HeartMate 3™ LVAD therapy might be a treatment option before their heart failure progresses, giving them more time to decide and plan for their heart failure treatment.
Here are a few points you might want to share with your patients:
- LVAD therapy is an option for patients with NYHA Class IIIB-IV heart failure
- HeartMate 3 LVAD is a small implantable pump that is designed to help their heart pump blood
- There have been significant clinical advancements in LVAD therapy, with HeartMate 3 LVAD survival rate now comparable to heart transplant at 2 years1,2*
- HeartMate 3 LVAD has an excellent safety profile, with reduced stroke and pump thrombosis adverse events rates3
Resources to Support LVAD Patient Education & Discussion
Live a More Active Life with an LVAD
Review fast facts and helpful information about living life with a HeartMate 3 LVAD.
HeartMate 3 Left Ventricular Assist Device (LVAD) Patient Guide
This patient guide is for using the HeartMate 3 LVAD that both the patient and caregiver will need to be familiar with upon hospital discharge.
HeartMate 3 LVAD Patient Education Handbook
This guide, created by the Advanced Cardiac Therapies Improving Outcomes Network (ACTION), is an easy-to-read education reference and scrapbook for patients to use on their LVAD journey.
HeartMate 3 LVAD Pediatric Patient Education Handbook
This pediatric handbook is a guide for young patients co-created with the Advanced Cardiac Therapies Improving Outcomes (ACTION) Network to help them navigate their LVAD journey.
Patient Education videos for understanding the HeartMate 3 LVAD pre-implant and post-implant.
*Based on published data from separate datasets, which may involve different patient populations and other variables. Not a head-to-head comparison. Data presented for informational purposes only.
References
- Teuteberg JJ, Cleveland JC, Cowger J, Higgins RS, et al. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: the changing landscape of devices and indications. Ann Thorac Surg. 2020;109:649-660.
- Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplant Report-2018: Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018:37:1155-1168.
- Mehra MR, Goldstein DJ, Cleveland JC, et al. Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. September 8, 2022.
MAT-2012376 v6.0
Stay Connected